title: The management of central neurocytoma: radiosurgery.
abstract: Stereotactic radiosurgery (SRS) has evolved into a mainstay in the primary and adjuvant management of most intracranial tumors. Central neurocytomas are rare, usually benign, intraventricular tumors that can be challenging to completely resect and often recur. Adjuvant therapy has been suggested for residual or recurrent tumors, especially in the setting of atypical neurocytomas. The limited data available suggest that SRS is a highly effective treatment approach for primary and adjuvant therapy, with tumor control rates of 80% to 90%. Due to its highly conformal and selective nature, SRS avoids the inconvenience and delayed toxicity of conventional radiation therapy.
authors.affiliation: Department of Neurological Surgery, University of Pittsburgh Medical Center, 200 Lothrop Street, Pittsburgh, PA 15213, USA. Electronic address: monacoea2@upmc.edu.
authors.forename: Edward A
authors.initials: EA
authors.lastname: Monaco
authors.affiliation: Department of Neurological Surgery, University of Pittsburgh Medical Center, 200 Lothrop Street, Pittsburgh, PA 15213, USA.
authors.forename: Ajay
authors.initials: A
authors.lastname: Niranjan
authors.affiliation: Department of Neurological Surgery, University of Pittsburgh Medical Center, 200 Lothrop Street, Pittsburgh, PA 15213, USA.
authors.forename: L Dade
authors.initials: LD
authors.lastname: Lunsford
mesh_terms: D002551:Cerebral Ventricle Neoplasms / Q000473:pathology / Q000601:surgery*; D006801:Humans; D018306:Neurocytoma / Q000473:pathology / Q000601:surgery*; D016634:Radiosurgery / Q000379:methods*
keywords: Central neurocytoma; Gamma Knife; Linear accelerator; Radiosurgery; Stereotactic radiosurgery